What is he best known for?
The fields of study he is best known for:
- Cancer
- Internal medicine
- Prostate cancer
His primary scientific interests are in Prostate cancer, Internal medicine, Oncology, Surgery and Cancer.
His study of Prostate-specific antigen is a part of Prostate cancer.
His research on Internal medicine often connects related areas such as Endocrinology.
His studies in Oncology integrate themes in fields like Chemotherapy, Adverse effect, Androgen deprivation therapy, Disease and Adenocarcinoma.
Celestia S. Higano combines subjects such as Prostatectomy, Placebo, Urology and Hazard ratio with his study of Surgery.
His study looks at the intersection of Cancer and topics like Immunology with Genotoxic Stress, Paracrine signalling, DNA damage and Wnt signaling pathway.
His most cited work include:
- Sipuleucel-T immunotherapy for castration-resistant prostate cancer. (3775 citations)
- Abiraterone in Metastatic Prostate Cancer without Previous Chemotherapy (1814 citations)
- Enzalutamide in Metastatic Prostate Cancer before Chemotherapy (1679 citations)
What are the main themes of his work throughout his whole career to date?
Celestia S. Higano mainly investigates Prostate cancer, Internal medicine, Oncology, Surgery and Docetaxel.
The Prostate cancer study combines topics in areas such as Cancer research and Prostate.
His is doing research in Enzalutamide, Clinical trial, Sipuleucel-T, Prostate-specific antigen and Chemotherapy, both of which are found in Internal medicine.
His study focuses on the intersection of Oncology and fields such as Hazard ratio with connections in the field of Proportional hazards model.
His research investigates the link between Surgery and topics such as Urology that cross with problems in Prednisone and Abiraterone acetate.
His work deals with themes such as Regimen and Mitoxantrone, which intersect with Docetaxel.
He most often published in these fields:
- Prostate cancer (89.66%)
- Internal medicine (65.30%)
- Oncology (51.29%)
What were the highlights of his more recent work (between 2019-2021)?
- Prostate cancer (89.66%)
- Internal medicine (65.30%)
- Oncology (51.29%)
In recent papers he was focusing on the following fields of study:
His scientific interests lie mostly in Prostate cancer, Internal medicine, Oncology, Castration resistant and Androgen deprivation therapy.
His biological study spans a wide range of topics, including Cancer research and Phases of clinical research.
His Oncology research incorporates elements of Concomitant, Cancer, Disease and Incidence.
The study incorporates disciplines such as Rehabilitation, Outpatient clinic, Brachytherapy and Sexual function in addition to Androgen deprivation therapy.
As part of the same scientific family, Celestia S. Higano usually focuses on Prostate-specific antigen, concentrating on Survival analysis and intersecting with Hazard ratio.
His Prednisone study combines topics in areas such as Abiraterone acetate and Zoledronic acid.
Between 2019 and 2021, his most popular works were:
- Management of Patients with Advanced Prostate Cancer: Report of the Advanced Prostate Cancer Consensus Conference 2019[Formula presented] (88 citations)
- Management of Patients with Advanced Prostate Cancer: Report of the Advanced Prostate Cancer Consensus Conference 2019[Formula presented] (88 citations)
- Non-BRCA DNA Damage Repair Gene Alterations and Response to the PARP Inhibitor Rucaparib in Metastatic Castration-Resistant Prostate Cancer: Analysis From the Phase II TRITON2 Study. (69 citations)
In his most recent research, the most cited papers focused on:
- Cancer
- Internal medicine
- Surgery
His primary areas of investigation include Prostate cancer, Internal medicine, Oncology, Cancer research and Progression-free survival.
His Prostate cancer study combines topics from a wide range of disciplines, such as Germline mutation, PARP inhibitor and Docetaxel.
His research in Internal medicine is mostly concerned with Enzalutamide.
His Enzalutamide research focuses on Placebo and how it relates to Hazard ratio and Confidence interval.
His research integrates issues of Cancer, Mood, Androgen, Dementia and Prostate-specific antigen in his study of Oncology.
His Cancer research research integrates issues from Polymerase, Talazoparib, DNA Damage Repair, Phases of clinical research and Castration resistant.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
